Products for Research Use Only

Tenifatecan

CAT: 0013-GTR19211828-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19211828-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Tenifatecan (SN2310) is a lipophilic derivative of the camptothecin analog SN-38, designed to enhance cellular uptake. It acts as a topoisomerase I inhibitor, demonstrating potent antitumor activity in both in vitro cytotoxicity assays and in vivo xenograft models across various cancer types.
CAS Number
850728-18-6
Product Name Alternative
SN 2310, SN2310, SN-2310, Tenifatecan
Field of Research
Molecular Biology
Purity
98.05% (May vary between batches)
Solubility
H2O:< 1 mg/mL (insoluble or slightly soluble) ; DMSO:< 1 mg/mL (insoluble or slightly soluble)
Smiles
C (C) C1=C2C (C=3N (C2) C (=O) C4=C (C3) [C@] (CC) (O) C (=O) OC4) =NC=5C1=CC (OC (CCC (OC=6C (C) =C7C (=C (C) C6C) O[C@@] (CCC[C@@H] (CCC[C@@H] (CCCC (C) C) C) C) (C) CC7) =O) =O) =CC5
Molecular Formula
C55H72N2O9
Molecular Weight
905.17
Storage Conditions
-20°C
Notes
For research use only.

Chemical Information

Tenifatecan

Tenifatecan is a highly lipophilic preparation of 7-Ethyl-10-hydroxycamptothecin (SN-38) with potential antineoplastic activity. SN2310 is an oil-in-water emulsion of tocopherol covalently linked, via a succinate linker, to SN-38, a synthetic derivative of the cytotoxic alkaloid camptothecin. After succinate linker is hydrolyzed in vivo, the active moiety SN-38 is released and selectively stabilizes topoisomerase I-DNA covalent complexes, thereby inhibiting religation of topoisomerase I-mediated single-stranded DNA breaks and inducing lethal double-stranded DNA breaks. This inhibits DNA replication and triggers programmed cell death. SN2310 emulsion provides longer circulation time and potentiates drug exposure as compared to the unconjugated SN-38.

CAS Number850728-18-6
PubChem CID11251571
IUPAC Name1-O-[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-O-[(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] butanedioate
Molecular FormulaC55H72N2O9
Molecular Weight905.2
XLogP12
Topological Polar Surface Area142
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count10
Rotatable Bond Count21
Heavy Atom Count66
Formal Charge0
Complexity1810
SMILES
CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)CCC(=O)OC6=C(C7=C(C(=C6C)C)O[C@](CC7)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C
InChI
InChI=1S/C55H72N2O9/c1-11-39-41-28-38(21-22-45(41)56-49-42(39)30-57-46(49)29-44-43(52(57)60)31-63-53(61)55(44,62)12-2)64-47(58)23-24-48(59)65-50-35(7)36(8)51-40(37(50)9)25-27-54(10,66-51)26-15-20-34(6)19-14-18-33(5)17-13-16-32(3)4/h21-22,28-29,32-34,62H,11-20,23-27,30-31H2,1-10H3/t33-,34-,54-,55+/m1/s1
InChIKey
KRHZRBUSQSYTTP-PTXGIJCNSA-N
Chemical Structure
2D Structure
2D structure of Tenifatecan
CAS: 850728-18-6
CID: 11251571
Formula: C55H72N2O9
MW: 905.2
Interactive 3D Structure
Loading 3D structure...
Computed Properties
PropertyValue
Molecular Weight905.2
XLogP312
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count10
Rotatable Bond Count21
Exact Mass904.52378188
Monoisotopic Mass904.52378188
Topological Polar Surface Area142 Ų
Heavy Atom Count66
Formal Charge0
Complexity1810
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Alternative Products